Interleukin (IL)-9-producing CD4 + T cells are a novel subset of T helper (Th) cells that develops independently of the Th1, Th2, Th17 and regulatory T-cell lineages. Similar to the murine model, transforming growth factor (TGF)-b and IL-4 directed human naive CD4 + T cells to produce IL-9. Whereas IL-4 suppressed TGF-b-induced Foxp3 expression, TGF-b failed to inhibit IL-4-mediated upregulation of the Th2 transcription factor GATA-3. Addition of IL-1b, IL-6, IL-10, interferon (IFN)-a, IFN-b or IL-21 to Th9-polarizing conditions augmented Th9 differentiation, while the Th1-associated cytokines IFN-c and IL-27 partially suppressed IL-9 production. Given that T cells are a primary source of IL-21, IL-21 expression was analyzed under Th9-polarizing conditions in the context of inflammatory cytokines. Surprisingly, type I IFNs induced elevated levels of IL-21, and blockade of IL-21 abrogated their ability to enhance Th9 differentiation. Taken together, these data indicate a complex cytokine network in the regulation of human IL-9-producing CD4 + T cells.
Upon recognition of a foreign antigen displayed by antigen-presenting cells, naive CD4 + T cells become activated and, depending on the cellular microenvironment, polarize into distinct lineages of T helper (Th) cells. 1 Th1 and Th2 cells were first described by Mossman and Coffman as subsets that regulate cellular and humoral immune responses, respectively. 2 Th1 development requires dendritic cellderived interleukin (IL)-12, which promotes the upregulation of the transcription factor T-bet and the secretion of interferon (IFN)-g to mediate defense against intracellular pathogens. 1 Disregulation of the Th1 response has been implicated in a number of inflammatory and autoimmune disorders. 3 In contrast, Th2 lineage commitment requires IL-4-mediated upregulation of the master regulatory transcription factor GATA-3. 1,4 Th2 cells secrete IL-4, IL-5 and IL-13 to mount immune responses against parasitic infections 1, 4 and are frequently linked to the pathogenesis of various allergic disorders. 5 In addition to the classical Th1 and Th2 lineages, the regulatory T cell (Treg) and Th17 subsets have been described and extensively characterized. Naïve CD4 + T cells cultured in the presence of transforming growth factor (TGF)-b upregulate the transcription factor Foxp3 and polarize into Tregs that mediate suppression of immune responses through the secretion of anti-inflammatory cytokines and cell contact-dependent mechanisms. 6, 7 Along with others, we have shown that human Th17 differentiation requires a cocktail of cytokines including IL-1b, IL-6, IL-21, IL-23 and TGF-b. [8] [9] [10] [11] [12] [13] Th17 cells express the transcriptional regulator RORgt and primarily secrete IL-17A, IL-17F and IL-22 to mediate immunity against extracellular bacteria and various fungal infections. 14 Disequilibrium of the Treg/ Th17 balance has been associated with numerous autoimmune diseases such as rheumatoid arthritis. 15, 16 Traditionally associated with the Th2 response, IL-9 is a member of the common gamma chain cytokine family and exerts broad effects on a variety of cell types such as mast cells, eosinophils, T cells and epithelial cells. 17 Two recent reports have identified in the murine system a distinct population of CD4 + T cells that produce IL-9 as well as IL-10, but lack the potential to secrete IFN-g, IL-4 or IL-17, 18,19 a profile suggesting a distinct lineage of CD4 + Th cells. Although the functional relevance of this novel lineage is still unclear, evidence suggests that these cells have an inflammatory role in a mouse model of colitis. 18 Murine Th9 cells require TGF-b in combination with IL-4 to redirect naive T cells from the Th2 lineage into an IL-9-producing subset, 18, 19 but this has not been confirmed in humans. In this study, we investigated the requirements for the induction and regulation of human Th9 cell differentiation.
RESULTS

Combinatorial addition of TGF-b and IL-4 promotes human Th9 differentiation
Starting with the hypothesis that TGF-b and IL-4 are required for IL-9 production in humans, fluorescence-activated cell sorting (FACS) purified naive CD4 + CD45RA + CD45RO À CD25 À T cells (499.9% purity) were cultured with TGF-b and IL-4 along with anti-CD3/ CD28 coated beads as an activating stimulus. As controls, naive T cells were cultured with beads in the absence of cytokine or in the presence of TGF-b alone or IL-4 alone. After 4 days, analysis of cell-free supernatants revealed that IL-4 alone induced low levels of IL-9 compared with the media alone or TGF-b alone controls. However, addition of TGF-b together with IL-4 potently induced high levels of IL-9 compared with all other conditions while suppressing IL-4-induced secretion of IL-5 and IL-13 ( Figure 1a Positive and negative regulation of human IL-9 production by inflammatory cytokines Having established the minimum requirements for generating human Th9 cells, we next performed a screen to determine whether additional inflammatory cytokines could regulate IL-9 secretion. Unexpectedly, a group of cytokines added individually to Th9-polarizing conditions upregulated IL-9, including IL-1b, IL-6, IL-10, IFN-a, IFN-b and IL-21 ( Figure 3a) . In some cases, IL-12 or IL-23 modestly enhanced IL-9 production in some donors, but this was not statistically significant across all donors (Figure 3a) . Addition of either IFN-g or IL-27 to Th9 conditions significantly inhibited IL-9 production in a dose-dependent manner (Figure 3b ). Given that IFN-g and IL-27 are associated with the Th1 lineage, 20 these data suggest that the Th1 response can negatively regulate the development of Th9 cells. However, this does not explain why the Th1-polarizing cytokine IL-12 failed to suppress-and in some cases, actually enhanced-human Th9 differentiation, indicating that IL-12 induces a factor that counteracts the inhibitory effects of IL-12-induced IFN-g. Figure 3) . Further analysis of intracellular IL-9 and IL-21 percentages by flow cytometry showed the same trends observed with ELISA (Figure 5b ), confirming that blocking IL-21 specifically inhibits Th9 differentiation as opposed to suppressing cell proliferation. IL-21R/Fc also downregulated intraellular IL-21 levels (Figure 5b) , which is consistent with the observation that IL-21 induces its own expression (Figure 4a ). In summary, these data strongly indicate that IL-21 is a critical enhancer of IL-9 production in humans. Memory Th9 cells are found within the CRTH2+ population To determine whether Th9 cells are present within the memory T-cell compartment, CD4 + CD45RO + CD45RA À T cells were freshly isolated from the peripheral blood of healthy donors and stained for intracellular expression of IL-4, IL-5, IL-13 and IL-9. Although memory T cells expressed detectable levels of intracellular IL-4, IL-5 and IL-13 (41% of memory cells), IL-9 comprised o0.1% of memory T cells (Figure 6a ). This low level of IL-9 expression was confirmed by ELISA after stimulation of unfractionated CD4 + memory cells with PMA and ionomycin ( Figure 6b ). As Th2 cells have been shown to express the surface marker CRTH2, 24, 25 we examined whether IL-9 producers were enriched within the CRTH2+ or CRTH2À populations. As expected, FACS-purified memory CD4 + CD45RA À CRTH2 + cells expressed elevated levels of the Th2 cytokines IL-4, IL-5 and IL-13 compared with CRTH2À and unfractionated memory T cells (Figure 6b and Supplementary Figure 4) . Sorting on CRTH2+ cells resulted in approximately threefold greater levels of IL-9 by ELISA (Figure 6b) , suggesting an association with the Th2 response.
TGF-b alone is required to expand memory Th9 cells
Given the low frequency of Th9 cells observed in memory CD4 + T cells, we next analyzed the requirements for expanding memory Th9 cells. Similar to the culture conditions described in Figure 1 Figure 1) . These data, along with the results generated with naive T cells, indicate that TGF-b is absolutely required for promoting the Th9 response in humans.
DISCUSSION
In this study, we have investigated the requirements for generating Th9 cells in humans. In contrast to the differences found between mice and humans with regard to Th17 polarization, [26] [27] [28] potent Th9 differentiation in humans seems to require the same cocktail of cytokines as observed in mice, 18, 19 TGF-b and IL-4. We performed our in vitro studies on highly purified naive T cells from the peripheral blood; however, it is critical that future studies use umbilical cord blood to definitely establish whether human Th9 cells derive from naive precursors. Furthermore, several inflammatory cytokines have the capacity to increase the frequency of IL-9-producing cells, most notably IFN-a, IFN-b and IL-21. Although Th9 cells are present at extremely low frequencies in the peripheral blood, these cells express the Th2 marker CRTH2 and require TGF-b for expansion from memory CD4 + T cells.
One question raised by this study is the complex signaling and transcriptional networks that lead to the production of IL-9 in humans. In spite of the downregulation of Foxp3 under Th9-polarizing conditions, GATA-3 expression is maintained, suggesting that GATA-3 is required for IL-9 production. However, these data do not rule out an unidentified transcription factor that can act alone or in combination with GATA-3 to promote the transcription of IL-9. This is supported by our data showing that Th9 cells do not express the Th2 cytokines IL-4, IL-5 and IL-13, suggesting that Th2 and Th9 cells develop along a reciprocal developmental pathway. The fact that several inflammatory cytokines, including IL-1b, IL-6, IL-10, IL-21 and type I IFNs, augment IL-9 production adds an additional layer of complexity to the regulation of Th9 differentiation. Several of these cytokines induce the phosphorylation of both STAT1 and STAT3 (data not shown), including IL-6, IL-10 and IL-21. Whether enhancement of IL-9 production is primarily mediated by one or both of these STAT proteins likely requires in vivo mouse models or studies using selective JAK or STAT inhibitors. Alternatively, human CD4 + T cells obtained from patients with either STAT1 or STAT3 mutations 29, 30 could be used to analyze the role of STAT proteins in regulating human Th9 differentiation.
The finding that type I IFNs induce IL-21 expression supports a recent study implicating a role for type I IFN signaling in the development of IL-21-producing T follicular helper cells. 31 These data also corroborate a study reporting that IFN-a and IFN-b upregulate IL-21 mRNA levels in activated human T cells. 32 Although we have also observed that IL-12 potently induces high levels of IL-21, our findings are inconsistent with a study that failed to identify a role for IFN-a in promoting IL-21 expression, 21 likely reflecting differences in in vitro culture systems. Thus, whether IL-21-producing T cells generated by type I IFNs demonstrate the properties of T follicular helper cells and whether T follicular helper cells regulate Th9 cells in vivo certainly requires further study. Another question that arises from these experiments is the functional relevance of Th9 cells, especially with regard to disease pathogenesis. Given that type I IFNs and IL-21 have both been shown to have a role in systemic lupus erythematosus, [33] [34] [35] [36] [37] analysis of IL-9-producing T cells as a possible mediator of autoantibody production in systemic lupus erythematosus warrants further investigation.
METHODS
Cell isolation and cultures
Enriched CD4 + T cells were prepared from buffy coats obtained from healthy donors (Stanford Blood Center after informed consent and Institutional 
Intracellular cytokine staining
After 4-day cultures, beads were magnetically removed and cells were restimulated with 25 ng ml -1 PMA and 750 ng ml -1 Ionomycin (Invitrogen) in the presence of Brefeldin A (eBioscience) for 4 h. Cells were then stained with a LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Invitrogen) according to the manufacturer's protocol, fixed with 1.6% paraformaldehyde and permeabilized with BD Perm/Wash buffer (BD Bioscience). Subsequently, cells were stained with fluorescently labeled Abs against IL-4, IL-5, IL-13, IL-9, IL-17 or IL-21 (eBioscience). For intracellular staining of transcription factors, beads were magnetically removed after 3 days of culture, and stained for viability as described above. Cells were then fixed and permeabilized (eBioscience) and stained with fluorescently labeled antibodies against GATA-3 (BD Bioscience) or Foxp3 (eBioscience). Labeled cells were analyzed on the BD LSRII (BD Bioscience), and FACS plots were further analyzed by FlowJo (Treestar, Ashland, OR, USA). All FACS plots shown are gated on singlets and live cells.
ELISA and statistical analysis
ELISA antibody pairs for IL-5 and IL-10 were obtained from eBioscience, while IL-9 and IL-13 antibody pairs were obtained from BD Bioscience. Samples were run in duplicate, and data and statistics were analyzed with GraphPad Prism (La Jolla, CA, USA). The Wilcoxon rank-sum test was used to analyze pairwise comparisons between conditions. For analysis of decreasing linear trends, 
